Introducing the new Kiloview Video! Embark on a journey of discovery with Kiloview cutting-edge video technology to provide stable AV over IP solutions worldwide. Kiloview Dayu Liu

July is Ultraviolet (UV) Safety Month, a topic which resonates with the xeroderma pigmentosum (XP) community. In his column, Richard Barlow, who lives with #XerodermaPigmentosum, discusses his life experiences. Read Richard's column at https://bit.ly/42UUWAW. Find out more about #XP by visiting Action for XP's website at actionforxp.org

Want to know one of the reasons we are partnering with MiracleFeet on Project 59? It's simple: they are innovators in their field. MiracleFeet designed the world's first 3-D interactive simulation of clubfoot. The model helps doctors practice correction sequences before and after in-person training. Users can rotate the foot 360 degrees and examine the underlying anatomical layers — bone and tendon structures of the foot. Practitioners all over the world use this simulation tool, including India, Guatemala, and Cambodia. This resource is an excellent way for people, even outside the medical field (like our team!), better understand one of the most common birth defects globally. Learn more about our partnership in Pakistan - https://lnkd.in/grAfibFY  

Great discussion on #POCUS and malpractice! If you want to read more, including a summary of the data, check out my @medpagetoday article on this topic: https://lnkd.in/ee5H4VdQ

Dr. Myers is joined by Dr. Boivin to discuss the medico-legal aspects of POCUS, including handheld machines, billing, and legal responsibility for incidental findings, in the latest Unmute Your Probe episode. Register for the course and listen: bit.ly/3TRLA6R #POCUS #Ultrasound #EmergencyMedicine

Listen in to the new format for Unmute Your Probe, where we will talk about cutting edge modalities and current controversies in point of care ultrasound!

<iframe title="vimeo-player" src="https://lnkd.in/ehY5zK4a" width="640" height="360" frameborder="0" allowfullscreen></iframe> BiVACOR is conducting an FDA-approved, first-in-human, Early Feasibility Study (EFS) that aims to evaluate the safety and performance of the BiVACOR TAH as a bridge-to-transplant solution for patients with severe biventricular heart failure or univentricular heart failure in which left ventricular assist device support is not recommended.

Those small steps

CMS is not called the Compact Muon Solenoid for nothing; the experiment is excellent at finding muons. #CMSpaper 1306 describes and measures how well muons are found, isolated and selected in (very busy) lead-lead collisions https://buff.ly/3z67JXL

CMS is not called the Compact Muon Solenoid for nothing; the experiment is excellent at finding muons. #CMSpaper 1306 describes and measures how well muons are found, isolated and selected in (very busy) lead-lead collisions https://buff.ly/3z67JXL